Drugs / SESC 01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03135912 | Jan → Aug 2017 | tinea pedis | South End Skin Care | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SESC 01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03135912 ↗ |
| Route | Topical | “Patients supplied with Experimental Drug SESC 01 for daily topical therapy for 4 weeks.” NCT03135912 ↗ |